| scholarly article | Q13442814 |
| P356 | DOI | 10.1155/1999/894803 |
| P698 | PubMed publication ID | 10202220 |
| P2093 | author name string | K R Chapman | |
| M Briggs | |||
| V Backer | |||
| N Ringdal | |||
| S Saarelainen | |||
| M Palmqvist | |||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | fluticasone propionate | Q8564098 |
| P304 | page(s) | 45-51 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | Canadian Respiratory Journal | Q5030529 |
| P1476 | title | Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers | |
| P478 | volume | 6 |
| Q24245719 | Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults |
| Q24240464 | Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children |
| Q24235303 | Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children |
| Q24235964 | Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma |
| Q43633581 | Characterisation of the aggregation behaviour in a salmeterol and fluticasone propionate inhalation aerosol system |
| Q24245383 | Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma |
| Q35180953 | Combination therapy: appropriate for everyone? |
| Q34620194 | Current trends in the treatment of asthma: focus on the simultaneous administration of salmeterol/fluticasone. |
| Q39335039 | Efficacy and Safety of Salmeterol/Fluticasone Propionate Combination Delivered by the Diskustrade mark or Pressurised Metered-Dose Inhaler in Children with Asthma |
| Q45152025 | Efficacy and acceptability of the fixed fluticasone + salmeterol combination in the treatment of acute asthma attacks. Results of a one-year comparative study |
| Q90247180 | Impact of Single Combination Inhaler versus Multiple Inhalers to Deliver the Same Medications for Patients with Asthma or COPD: A Systematic Literature Review |
| Q36795433 | Improvement of eosinophilic otitis media by optimized asthma treatment |
| Q34167388 | Inhaled salmeterol/fluticasone propionate combination. A pharmacoeconomic review of its use in the management of asthma |
| Q35213448 | Inhaled salmeterol/fluticasone propionate combination: a pharmacoeconomic review of its use in the management of asthma |
| Q34112937 | Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma |
| Q36214689 | Inhaled salmeterol/fluticasone propionate: a review of its use in asthma |
| Q88542181 | Inhaled steroids with and without regular salmeterol for asthma: serious adverse events |
| Q24245643 | Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma |
| Q35070070 | Lung deposition of BDP/formoterol HFA pMDI in healthy volunteers, asthmatic, and COPD patients |
| Q37800043 | Patient-reported outcomes in clinical trials of inhaled asthma medications: systematic review and research needs |
| Q26797460 | Real-world research and its importance in respiratory medicine |
| Q24199079 | Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events |
| Q24241740 | Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events |
| Q38930261 | Routine Use of Budesonide/Formoterol Fixed Dose Combination in Elderly Asthmatic Patients: Practical Considerations |
| Q33684269 | Salmeterol/fluticasone propionate combination |
| Q37589610 | Salmeterol/fluticasone propionate: a review of its use in asthma. |
| Q39335010 | Short-term safety and tolerability of double-dose salmeterol/fluticasone propionate in adult asthmatic patients |
| Q34623797 | Treatment of moderate to severe asthma: patient perspectives on combination inhaler therapy and implications for adherence |
Search more.